WAGNER CHARLES F JR 4

What Happened Charles F. Wagner Jr., Executive Vice President, CO & FO of Vertex Pharmaceuticals (VRTX), had 3,045 shares withheld on Feb 10, 2026 to satisfy a tax liability related to an equity award or option exercise. The shares were recorded at $468.41 each for a total value of approximately $1,426,308. This was a tax-withholding disposition (code F), not an open-market sale.

Key Details

• Transaction date and price: 2026-02-10, 3,045 shares @ $468.41.
• Total value withheld: ~$1,426,308.
• Shares owned after transaction: Not disclosed in the filing excerpt provided.
• Transaction code/footnote: F = payment of exercise price or tax liability via delivery/withholding of shares (share surrender/withholding).
• Filing timeliness: Form filed 2026-02-12 for a 2026-02-10 transaction — filed within the typical 2-business-day window (not reported as late).

Context This action is a routine administrative tax-withholding event that commonly follows option exercises or restricted stock vesting. Because shares were withheld to cover taxes rather than sold on the open market, this transaction does not necessarily indicate additional insider selling pressure or a change in the insider’s view of the company.